View in EDS HTML Full Text PDF Full Text

A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.

Saved in:
Bibliographic Details
Title: A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Authors: Zibelman M; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. matthew.zibelman@fccc.edu., MacFarlane AW 4th; Immune Monitoring/Cell Sorting Facility, Institute for Cancer Research, Philadelphia, PA, USA., Costello K; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA., McGowan T; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA., O'Neill J; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Kokate R; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Borghaei H; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Denlinger CS; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Dotan E; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Geynisman DM; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Jain A; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Martin L; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Obeid E; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Devarajan K; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA., Ruth K; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA., Alpaugh RK; Protocol Support Laboratory, Fox Chase Cancer Center, Philadelphia, PA, USA., Dulaimi EA; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA., Cukierman E; Cancer Signaling and Microenvironment Program, Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Einarson M; High Throughput Screening Facility, Fox Chase Cancer Center, Philadelphia, PA, USA., Campbell KS; Immune Monitoring/Cell Sorting Facility, Institute for Cancer Research, Philadelphia, PA, USA., Plimack ER; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Source: Nature communications [Nat Commun] 2023 Jul 27; Vol. 14 (1), pp. 4513. Date of Electronic Publication: 2023 Jul 27.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37500647
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zibelman+M%22">Zibelman M</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. matthew.zibelman@fccc.edu.<br /><searchLink fieldCode="AU" term="%22MacFarlane+AW+4th%22">MacFarlane AW 4th</searchLink>; Immune Monitoring/Cell Sorting Facility, Institute for Cancer Research, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Costello+K%22">Costello K</searchLink>; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22McGowan+T%22">McGowan T</searchLink>; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22O'Neill+J%22">O'Neill J</searchLink>; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kokate+R%22">Kokate R</searchLink>; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Borghaei+H%22">Borghaei H</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Denlinger+CS%22">Denlinger CS</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Dotan+E%22">Dotan E</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Geynisman+DM%22">Geynisman DM</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Jain+A%22">Jain A</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Martin+L%22">Martin L</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Obeid+E%22">Obeid E</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Devarajan+K%22">Devarajan K</searchLink>; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ruth+K%22">Ruth K</searchLink>; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Alpaugh+RK%22">Alpaugh RK</searchLink>; Protocol Support Laboratory, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Dulaimi+EA%22">Dulaimi EA</searchLink>; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Cukierman+E%22">Cukierman E</searchLink>; Cancer Signaling and Microenvironment Program, Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Einarson+M%22">Einarson M</searchLink>; High Throughput Screening Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+KS%22">Campbell KS</searchLink>; Immune Monitoring/Cell Sorting Facility, Institute for Cancer Research, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Plimack+ER%22">Plimack ER</searchLink>; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Jul 27; Vol. 14 (1), pp. 4513. <i>Date of Electronic Publication: </i>2023 Jul 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37500647
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-023-40028-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4513
    Titles:
      – TitleFull: A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zibelman M
      – PersonEntity:
          Name:
            NameFull: MacFarlane AW 4th
      – PersonEntity:
          Name:
            NameFull: Costello K
      – PersonEntity:
          Name:
            NameFull: McGowan T
      – PersonEntity:
          Name:
            NameFull: O'Neill J
      – PersonEntity:
          Name:
            NameFull: Kokate R
      – PersonEntity:
          Name:
            NameFull: Borghaei H
      – PersonEntity:
          Name:
            NameFull: Denlinger CS
      – PersonEntity:
          Name:
            NameFull: Dotan E
      – PersonEntity:
          Name:
            NameFull: Geynisman DM
      – PersonEntity:
          Name:
            NameFull: Jain A
      – PersonEntity:
          Name:
            NameFull: Martin L
      – PersonEntity:
          Name:
            NameFull: Obeid E
      – PersonEntity:
          Name:
            NameFull: Devarajan K
      – PersonEntity:
          Name:
            NameFull: Ruth K
      – PersonEntity:
          Name:
            NameFull: Alpaugh RK
      – PersonEntity:
          Name:
            NameFull: Dulaimi EA
      – PersonEntity:
          Name:
            NameFull: Cukierman E
      – PersonEntity:
          Name:
            NameFull: Einarson M
      – PersonEntity:
          Name:
            NameFull: Campbell KS
      – PersonEntity:
          Name:
            NameFull: Plimack ER
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 07
              Text: 2023 Jul 27
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1